405
Participants
Start Date
December 21, 2020
Primary Completion Date
October 24, 2024
Study Completion Date
August 31, 2025
Endovascular treatment of intracranial aneurysms using a flow-diverting stent
The flow diverter brings about a reduction of blood flow to the aneurysm, which progresses over time into forming a stable thrombus within the aneurysm, as well as eventual aneurysm scarring and retraction. The flow diverter also acts as a scaffold for tissue growth across the neck of the aneurysm, which blocks the aneurysm from the artery blood flow.
Uniklinik Salzburg, Salzburg
Helsinki University Hospital, Helsinki
Turku University Hospital, Turku
CHU Amiens, Amiens
CHRU Besançon, Besançon
CHU Pellegrin Bordeaux, Bordeaux
CHU Cavale Blanche Brest, Brest
CHU Clermont-Ferrand, Clermont-Ferrand
Henri Mondor Créteil, Créteil
CHU la Tronche Grenoble, La Tronche
CHU Lille, Lille
CHU Bron-Lyon, Lyon
CHU la Timone Marseille, Marseille
CHU Montpellier, Montpellier
CHU Nancy, Nancy
Hospital Fondation Rothschild - Paris, Paris
La Pitié Salpétrière, Paris
NEURI, Kremlin Bicêtre, Paris
CHU Rennes, Rennes
CHU Charles Nicolle Rouen, Rouen
CHU Saint Etienne, Saint-Etienne
CHU Bretonneau Tours, Tours
Universitatsklinikum Augsburg A.o.R, Augsburg
University Hospital Knappschaftskrankenhaus Bochum, Bochum
AO Careggi Hospital, Florence
Ospedale Policlinico San Martino, Genova
Grande Ospedale Metropolitano Niguarda, Milan
Fondazione Policlinico Universitario A. Gemelli, Rome
Inselspital Bern, Bern
University Hospital of Zurich, Zurich
Queen Elizabeth Hospital, Birmingham
NHS Lothian, Edinburgh
Stryker Neurovascular
INDUSTRY